Hims just went public. What does that mean for the future of healthcare?

The online pharmacy caters to busy people who don’t have a primary doctor. But we shouldn’t rush to ditch healthcare in its more traditional form.

Hims, a heavily branded online pharmacy with a limited range of products, began trading as a public company on Thursday at $17.08 per share. Its price dropped 7% over the course of the day. The company went public through a merger with special purpose acquisition company (SPAC) Oaktree Acquisition Corp, which closed on Wednesday. The deal valued Hims at $1.6 billion.

Read Full Story